Please login to the form below

Not currently logged in
Email:
Password:

Anavex

This page shows the latest Anavex news and features for those working in and with pharma, biotech and healthcare.

Anavex sets up trial of ‘triple-action’ Alzheimer’s drug

Anavex sets up trial of ‘triple-action’ Alzheimer’s drug

But the biotech thinks that the broad activity of Anavex 2-73 and biomarker-driven clinical trials elevate its chances of success. ... It is planning to use a similar process and trial design for a phase II study of Anavex 2-73 in Parkinson’s disease.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics